Elicio Therapeutics, Inc. (ELTX:NASDAQ) closed at $1.90 on October 23, 2026, down 2.06% on the day. The stock trades 88.1% below its 52-week high of $16.00 and 31.9% above its 52-week low of $1.44. Over the past year, it lost 80.4%. Elicio Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, ELTX closed higher on 107 days (42%). Its best day was June 17, 2026 (+70.65%) and its worst was June 15, 2026 (-72.53%). The stock moved 10% or more in a single session 19 times. It opened at least 5% above the previous day's high 1 time.
Elicio Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases.
Find more stocks like ELTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.